|
PGBD4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.082160E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.645000E-04 |
| Normal-vs-Stage2 |
4.279200E-01 |
| Normal-vs-Stage3 |
1.97478999999223E-05 |
| Normal-vs-Stage4 |
9.481600E-01 |
| Stage1-vs-Stage2 |
2.628400E-01 |
| Stage1-vs-Stage3 |
1.574420E-01 |
| Stage1-vs-Stage4 |
3.409200E-01 |
| Stage2-vs-Stage3 |
7.986200E-02 |
| Stage2-vs-Stage4 |
7.055000E-01 |
| Stage3-vs-Stage4 |
1.907770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.623700E-04 |
| Normal-vs-AfricanAmerican |
2.011700E-02 |
| Normal-vs-Asian |
3.257200E-03 |
| Caucasian-vs-AfricanAmerican |
2.673800E-01 |
| Caucasian-vs-Asian |
2.854000E-01 |
| AfricanAmerican-vs-Asian |
2.137000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.802530E-04 |
| Normal-vs-Female |
3.145500E-02 |
| Male-vs-Female |
3.545700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.284300E-02 |
| Normal-vs-Extreme_Weight |
3.96650000000776E-06 |
| Normal-vs-Obese |
6.461300E-03 |
| Normal-vs-Extreme_Obese |
5.463400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.498300E-02 |
| Normal_Weight-vs-Obese |
5.184800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.106800E-01 |
| Extreme_Weight-vs-Obese |
1.308210E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.215200E-01 |
| Obese-vs-Extreme_Obese |
3.792800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.375200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.035730E-02 |
| Normal-vs-Age(61-80Yrs) |
1.431990E-04 |
| Normal-vs-Age(81-100Yrs) |
2.941200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.577040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.246800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.748600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.886300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.817560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.240200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.567900E-04 |
| Normal-VS-Type2 PRCC |
2.578200E-03 |
| Normal-VS-KIRP CIMP |
4.391100E-04 |
| Normal-VS-Unclassified PRCC |
3.602200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.766800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.818990E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.800400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.357600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.274800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.208410E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.015700E-04 |
| Normal-vs-N1 |
1.104000E-01 |
| Normal-vs-N2 |
7.064200E-02 |
| N0-vs-N1 |
5.996800E-01 |
| N0-vs-N2 |
9.493600E-01 |
| N1-vs-N2 |
7.997200E-01 |
|
|
